Details for New Drug Application (NDA): 072514
✉ Email this page to a colleague
The generic ingredient in CLORAZEPATE DIPOTASSIUM is clorazepate dipotassium. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the clorazepate dipotassium profile page.
Summary for 072514
Tradename: | CLORAZEPATE DIPOTASSIUM |
Applicant: | Aurolife Pharma Llc |
Ingredient: | clorazepate dipotassium |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 072514
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 15MG | ||||
Approval Date: | May 11, 1990 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 3.75MG | ||||
Approval Date: | May 11, 1990 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 7.5MG | ||||
Approval Date: | May 11, 1990 | TE: | RLD: | No |
Complete Access Available with Subscription